Target intelligence / Profile preview

General microbial biomolecules (PAMPs)

Target
PAMPs
Molecular classification
Other, Microbial components, Polysaccharides, Proteins, Nucleic acids
01

Overview

General microbial biomolecules refers to a broad and heterogeneous group of molecules derived from microorganisms, including bacteria, viruses, fungi, and protozoa. These molecules encompass essential structural components such as peptidoglycan, lipopolysaccharides (LPS), and viral capsids, as well as functional molecules like enzymes and nucleic acids (Silhavy et al., 2010). In the context of immunology, many of these are classified as Pathogen-Associated Molecular Patterns (PAMPs), which are recognized by host Pattern Recognition Receptors (PRRs), such as Toll-like receptors, to initiate an innate immune response (Janeway & Medzhitov, 2002). While not a single therapeutic target, these biomolecules are the focus of anti-infective therapies, where drugs aim to disrupt their synthesis or function to treat infections (Kohanski et al., 2010). For example, beta-lactam antibiotics target the synthesis of peptidoglycan in bacterial cell walls. Understanding these molecules is crucial for developing vaccines, which often use microbial biomolecules as antigens, and diagnostic tools to identify specific pathogens in clinical settings.

Other names
Microbial componentsPathogen-associated molecular patternsPAMPsMicrobial antigensMicrobial structural molecules
02

Mechanism of action

Varies by specific biomolecule; includes inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis, or interference with nucleic acid replication (Kohanski et al., 2010).

03

Biological functions

Immune response inductionPathogenesisMicrobial metabolismCell wall integrityGenetic information storage
04

Disease associations

InfectionSepsisInflammationAutoimmunity (via molecular mimicry)
05

Safety considerations

Antimicrobial resistanceDisruption of commensal microbiomeJarisch-Herxheimer reactionToxicity (e.g., nephrotoxicity of certain antibiotics)
06

Interacting drugs

Penicillin

4 more in the full profile.

07

Biomarkers

ProcalcitoninC-reactive protein (CRP)Microbial DNA/RNA (via PCR)1,3-beta-D-glucanGalactomannan

Beyond the preview

Go deeper on General microbial biomolecules (PAMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General microbial biomolecules (PAMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call